HCC recurrence after DAA treatment in HCV patients

被引：0
|
作者：
Guarino, Maria [1 ]
Bruzzese, Dario [2 ]
Di Costanzo, Giovan Giuseppe [3 ]
Guarracino, Marco [3 ]
Morando, Federica [1 ]
Sessa, Anna [1 ]
Rinaldi, Luca [4 ]
Persico, Marcello [5 ]
Megna, Angelo Salomone [6 ]
Nicola, Coppola [7 ]
Cossiga, Valentina [1 ]
Caporaso, Nicola [1 ]
Morisco, Filomena [1 ]
机构：
[1] Univ Naples Federico II, Gastroenterol Unit, Dept Clin Med & Surg, Naples, Italy
[2] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
[3] Cardarelli Hosp, Hepatol Unit, Naples, Italy
[4] Univ Campania Luigi Vanvitelli, Dept Med Surg, Neurol Geriatr & Metab Sci, Naples, Italy
[5] Univ Salerno, Dept Med & Surg, Salerno, Italy
[6] Rummo Hosp, Div Infect Dis, Benevento, Italy
[7] Univ Campania Luigi Vanvitelli, Dept Mental Hlth & Publ Med, Sect Infect Dis, Naples, Italy
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31668-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-461
引用
收藏
页码：E835 / E836
页数：2
相关论文
共 50 条
  • [1] HCC RECURRENCE AFTER DAA TREATMENT IN HCV PATIENTS
    Guarino, M.
    Bruzzese, D.
    Di Costanzo, G. G.
    Guarracino, M.
    Morando, F.
    Sessa, A.
    Rinaldi, L.
    Persico, M.
    Megna, A. Salomone
    Coppola, N.
    Caporaso, N.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E95 - E95
  • [2] HCC recurrence after DAA treatment in HCV patients
    Guarino, M.
    Bruzzese, D.
    Di Costanzo, G. G.
    Guarracino, M.
    Morando, F.
    Rinaldi, L.
    Persico, M.
    Megna, A. Salomone
    Coppola, N.
    Caporaso, N.
    Morisco, F.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 50 - 50
  • [3] Timing of DAA Initiation After Curative Treatment and Its Relationship with the Recurrence of HCV-Related HCC
    Gao, Xiuzhu
    Zhan, Mengru
    Wang, Liquan
    Ding, Yanhua
    Niu, Junqi
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2020, 7 : 347 - 360
  • [4] DENOVO VS RECURRENCE OF HCC IN HCV INFECTED PATIENTS TREATED WITH DAA'S
    Syed, Taseen A.
    Ali, Ijlal Akbar
    Mahmood, Sultan
    Fazili, Javid
    GASTROENTEROLOGY, 2018, 154 (06) : S952 - S953
  • [5] The incidence of Denovo HCC or aggressive recurrence of HCC in patients with HCV infection receiving DAA therapy.
    Yousif, Sarra
    Al-Hamoudi, Waleed K.
    Abaalkhail, Faisal A.
    Elsiesy, Hussein A.
    Al Sebayel, Mohammed
    Shawkat, Mohamed
    Kuriry, Hadi M.
    Elbeshbeshy, Hany A.
    HEPATOLOGY, 2017, 66 : 780A - 780A
  • [6] Impact of curative HCC history on the development of HCC after the eradication of HCV by DAA therapy in patients with HCV infection
    Toyoda, H.
    Kumada, T.
    Tada, T.
    Mizuno, K.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S529 - S530
  • [7] TREATMENT OF HCV IN HCC PATIENTS AFTER LIVER TRANSPLANTATION IMPROVES SURVIVAL AND DECREASES RISK OF HCC RECURRENCE
    Niyazi, Fadi
    Sanghi, Vedha
    Abduljawad, Baraa
    Asfari, Mohammad Maysara
    Lopez, Rocio
    Menon, K. V. Narayanan
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2017, 152 (05) : S1103 - S1103
  • [8] Extrahepatic tumor recurrence after directlyactingantiviral (DAA) therapy in HCV patients
    Torres, M. C. Plaz
    Lamonaca, L.
    De Nalda, A. Lleo
    Ceriani, R.
    Rimassa, L.
    Personeni, N.
    Colombo, M.
    Aghemo, A.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E63 - E63
  • [9] HCC recurrence in HCV patients after liver transplantation in the DAA treatment era: SiLVER Study subgroup analysis reveals sirolimus treatment in combination with CNIs is an excellent treatment option
    Werner, J. M.
    Hornung, M.
    Krah, R.
    Schlitt, H. J.
    Geissler, E. K.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 61 - 61
  • [10] After HCC: DAA Therapy for HCV Infection Patients significantly reduces Mortality Risk
    Gappa, Birgit
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (01): : 22 - +
12345